InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.33
(
0.36%
)
Bitcoin
62,850.45
(
-0.49%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bob smith

Send PM Follow Ignore
Followers 27
Posts 2850
Boards Moderated 0
Alias Born 10/17/2009

bob smith

Re: None

Monday, 03/05/2012 7:04:32 AM

Monday, March 05, 2012 7:04:32 AM

Post# of 97239
Endocyte to Resume Patient Enrollment in PROCEED Phase 3 Trial in U.S.

This is great news, as there was some concern about even getting a phase 3 study for the European approval this year. This was expressed during the last conference call/ presentation at the end of February.


Moving forward.


gl
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up